Partner Content Partner Content 4th Annual Genome Editing USA Congress 2 days, 350+ end users, 80+ case studies
Events Partner Content CRISPR Congress Europe 2018 | Genome Evolution Conference Join Precision CRISPR Gene Editing Community in Europe
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.